• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

lifitegrast对白内障手术干眼患者屈光准确性及症状的影响。

The Effect of Lifitegrast on Refractive Accuracy and Symptoms in Dry Eye Patients Undergoing Cataract Surgery.

作者信息

Hovanesian John, Epitropoulos Alice, Donnenfeld Eric D, Holladay Jack T

机构信息

Harvard Eye Associates, Laguna Hills, CA, USA.

Ophthalmic Surgeons & Consultants of Ohio, Columbus, OH, USA.

出版信息

Clin Ophthalmol. 2020 Sep 16;14:2709-2716. doi: 10.2147/OPTH.S264520. eCollection 2020.

DOI:10.2147/OPTH.S264520
PMID:32982163
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7502384/
Abstract

PURPOSE

To determine the effect of lifitegrast ophthalmic solution 5% on improving the tear film, biometry/keratometry, and refractive accuracy for dry eye patients scheduled for cataract surgery.

PATIENTS AND METHODS

Multicenter, prospective, open-label study of 100 eyes of 100 patients undergoing cataract surgery who had a confirmed diagnosis of dry eye. Patients underwent biometry at baseline and again after a 28-day course of lifitegrast 5% BID. Primary outcome was an improvement in the accuracy of preoperative anterior corneal power measurements at predicting postoperative spherical equivalent (SE) pre- and post-lifitegrast treatment. Secondary outcomes included changes in dry eye symptoms and corneal staining.

RESULTS

The accuracy of the biometry readings for the achieved refractive SE: within 0.25 D in 47% and 50% of eyes before and after the initial lifitegrast treatment, respectively; within 0.5 D in 71% and 79% of eyes before and after the initial lifitegrast treatment; and within 0.75 D in 81% and 91% of eyes before and after the initial lifitegrast treatment (p < 0.04).

CONCLUSION

Lifitegrast 5% significantly improved preoperative corneal surface measurement accuracy in patients with confirmed dry eye who were scheduled for cataract surgery.

摘要

目的

确定5%的lifitegrast眼药水对计划进行白内障手术的干眼患者泪膜、生物测量/角膜曲率测量及屈光准确性的改善效果。

患者与方法

对100例确诊为干眼且计划进行白内障手术的患者的100只眼睛进行多中心、前瞻性、开放标签研究。患者在基线时进行生物测量,在接受28天每日两次的5%lifitegrast治疗后再次进行生物测量。主要结局是在lifitegrast治疗前后,术前角膜前表面屈光力测量在预测术后等效球镜度(SE)方面的准确性提高。次要结局包括干眼症状和角膜染色的变化。

结果

对于达到的屈光SE,生物测量读数的准确性:在初始lifitegrast治疗前,分别有47%和50%的眼睛在0.25 D以内;在初始lifitegrast治疗后,分别有71%和79%的眼睛在0.5 D以内;在初始lifitegrast治疗前,分别有81%和91%的眼睛在0.75 D以内(p < 0.04)。

结论

5%的lifitegrast显著提高了计划进行白内障手术的确诊干眼患者术前角膜表面测量的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a46/7502384/31090315d345/OPTH-14-2709-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a46/7502384/295eccdf85e8/OPTH-14-2709-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a46/7502384/9ae119efef1a/OPTH-14-2709-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a46/7502384/cdf506710ef0/OPTH-14-2709-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a46/7502384/31090315d345/OPTH-14-2709-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a46/7502384/295eccdf85e8/OPTH-14-2709-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a46/7502384/9ae119efef1a/OPTH-14-2709-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a46/7502384/cdf506710ef0/OPTH-14-2709-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a46/7502384/31090315d345/OPTH-14-2709-g0004.jpg

相似文献

1
The Effect of Lifitegrast on Refractive Accuracy and Symptoms in Dry Eye Patients Undergoing Cataract Surgery.lifitegrast对白内障手术干眼患者屈光准确性及症状的影响。
Clin Ophthalmol. 2020 Sep 16;14:2709-2716. doi: 10.2147/OPTH.S264520. eCollection 2020.
2
The Effect of Rebamipide on Refractive Accuracy of Cataract Surgery in Patients with Dry Eye.瑞巴派特对干眼患者白内障手术屈光准确性的影响。
Ophthalmol Ther. 2022 Apr;11(2):603-611. doi: 10.1007/s40123-022-00457-3. Epub 2022 Jan 22.
3
Effect of Cyclosporine 0.09% Treatment on Accuracy of Preoperative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery.0.09%环孢素治疗对白内障手术干眼患者术前生物测量准确性及高阶像差的影响。
Clin Ophthalmol. 2021 Sep 1;15:3679-3686. doi: 10.2147/OPTH.S325659. eCollection 2021.
4
Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.利福平眼科溶液 5.0%对比安慰剂治疗干眼疾病:随机 III 期 OPUS-2 研究结果。
Ophthalmology. 2015 Dec;122(12):2423-31. doi: 10.1016/j.ophtha.2015.08.001. Epub 2015 Sep 11.
5
Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.利福平眼科溶液 5.0%治疗干眼症:OPUS-1 期 3 研究结果。
Ophthalmology. 2014 Feb;121(2):475-83. doi: 10.1016/j.ophtha.2013.09.015. Epub 2013 Nov 26.
6
Six months' treatment with lifitegrast in patients with moderate-to-severe symptomatic dry eye: a retrospective chart review.在中度至重度症状性干眼症患者中使用lifitegrast进行六个月治疗:一项回顾性病历审查。
Clin Ophthalmol. 2019 Jun 19;13:1033-1037. doi: 10.2147/OPTH.S191635. eCollection 2019.
7
Improved Refractive Outcomes of Small-Incision Extracapsular Cataract Surgery after Implementation of a Biometry Training Course.实施生物测量培训课程后小切口白内障囊外摘除术屈光效果的改善
Middle East Afr J Ophthalmol. 2019 Jan-Mar;26(1):17-22. doi: 10.4103/meajo.MEAJO_3_18.
8
Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.5.0% 利非司特滴眼液的安全性和耐受性:干眼疾病五项随机对照试验的汇总分析
Eur J Ophthalmol. 2019 Jul;29(4):394-401. doi: 10.1177/1120672118791936. Epub 2018 Aug 16.
9
Dry Eye Disease as a Cause of Refractive Errors After Cataract Surgery - A Systematic Review.白内障手术后屈光不正的病因——干眼疾病:一项系统评价
Clin Ophthalmol. 2023 Jun 6;17:1629-1638. doi: 10.2147/OPTH.S406530. eCollection 2023.
10
Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3).利福平格拉司特治疗干眼疾病的 III 期、随机、双盲、安慰剂对照试验(OPUS-3)结果。
Ophthalmology. 2017 Jan;124(1):53-60. doi: 10.1016/j.ophtha.2016.09.025. Epub 2016 Oct 27.

引用本文的文献

1
Real-World Experience with Lifitegrast Ophthalmic Solution in Patients with Dry Eye Disease: A Provider Survey in the USA and Canada.干眼症患者使用lifitegrast眼药水的真实世界经验:美国和加拿大的一项医疗服务提供者调查。
Ophthalmol Ther. 2025 Jul 10. doi: 10.1007/s40123-025-01190-3.
2
Optimization of the Ocular Surface Prior to Cataract Surgery Using Cryopreserved Amniotic Membrane.使用冷冻保存的羊膜在白内障手术前优化眼表
Clin Ophthalmol. 2025 Jun 25;19:1975-1983. doi: 10.2147/OPTH.S525438. eCollection 2025.
3
Comparison of Postoperative Outcomes in 71 Patients Undergoing Cataract Surgery at a Single Center with and Without Preoperative Keratostill Moisturizing Eye Drops.

本文引用的文献

1
Predictors of patient compliance with follow-up visits after cataract surgery.白内障手术后患者随访依从性的预测因素。
J Cataract Refract Surg. 2019 Aug;45(8):1105-1112. doi: 10.1016/j.jcrs.2019.02.024. Epub 2019 Jun 4.
2
Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.5.0% 利非司特滴眼液的安全性和耐受性:干眼疾病五项随机对照试验的汇总分析
Eur J Ophthalmol. 2019 Jul;29(4):394-401. doi: 10.1177/1120672118791936. Epub 2018 Aug 16.
3
The Prospective Health Assessment of Cataract Patients' Ocular Surface (PHACO) study: the effect of dry eye.
单中心71例白内障手术患者术前使用与未使用角膜保湿滴眼液的术后结果比较。
J Clin Med. 2025 Jun 18;14(12):4349. doi: 10.3390/jcm14124349.
4
Effect of Preoperative Dry Eye Treatment with Intense Pulsed Light with Meibomian Gland Expression on the Refractive Accuracy of Cataract Surgery in Patients with Meibomian Gland Dysfunction-Related Dry Eye: A Single-Center, Prospective, Open-Label Study.强脉冲光联合睑板腺按摩进行术前干眼治疗对睑板腺功能障碍相关性干眼患者白内障手术屈光准确性的影响:一项单中心、前瞻性、开放标签研究
J Clin Med. 2025 Apr 18;14(8):2805. doi: 10.3390/jcm14082805.
5
To evaluate the effects of artificial tears on ocular biological parameters in dry eye and non-dry eye patients.评估人工泪液对干眼和非干眼患者眼部生物学参数的影响。
Sci Rep. 2025 Apr 11;15(1):12392. doi: 10.1038/s41598-025-95801-5.
6
The THINK Study: Testing Hypoesthesia and the Incidence of Neurotrophic Keratopathy in Cataract Patients with Dry Eye.THINK研究:检测干眼白内障患者的感觉减退及神经营养性角膜病变的发生率
Clin Ophthalmol. 2024 Dec 6;18:3627-3633. doi: 10.2147/OPTH.S501452. eCollection 2024.
7
Cataract and diabetes: review of the literature.白内障与糖尿病:文献综述
J Cataract Refract Surg. 2024 Dec 1;50(12):1275-1283. doi: 10.1097/j.jcrs.0000000000001547.
8
Management of Dry Eye Disease for Intraocular Lens Power Calculation in Cataract Surgery: A Systematic Review.白内障手术中人工晶状体屈光度计算的干眼疾病管理:一项系统评价
Bioengineering (Basel). 2024 Jun 11;11(6):597. doi: 10.3390/bioengineering11060597.
9
Effect of Artificial Tears on Preoperative Keratometry and Refractive Precision in Cataract Surgery.人工泪液对白内障手术术前角膜曲率测量及屈光精度的影响。
Clin Ophthalmol. 2024 May 28;18:1503-1514. doi: 10.2147/OPTH.S459282. eCollection 2024.
10
Artificial Tear Instillation-Induced Changes in Corneal Topography.人工泪液滴注引起的角膜地形图变化。
Bioengineering (Basel). 2024 Jan 26;11(2):121. doi: 10.3390/bioengineering11020121.
白内障患者眼表的前瞻性健康评估(PHACO)研究:干眼的影响
Clin Ophthalmol. 2017 Aug 7;11:1423-1430. doi: 10.2147/OPTH.S120159. eCollection 2017.
4
Lifitegrast for the treatment of dry eye disease in adults.Lifitegrast用于治疗成人干眼症。
Expert Opin Pharmacother. 2017 Oct;18(14):1517-1524. doi: 10.1080/14656566.2017.1372748. Epub 2017 Sep 4.
5
The effect of ocular biometric factors on the accuracy of various IOL power calculation formulas.眼部生物测量因素对各种人工晶状体屈光力计算公式准确性的影响。
BMC Ophthalmol. 2017 May 2;17(1):62. doi: 10.1186/s12886-017-0454-y.
6
Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3).利福平格拉司特治疗干眼疾病的 III 期、随机、双盲、安慰剂对照试验(OPUS-3)结果。
Ophthalmology. 2017 Jan;124(1):53-60. doi: 10.1016/j.ophtha.2016.09.025. Epub 2016 Oct 27.
7
Lifitegrast Ophthalmic Solution 5%: A Review in Dry Eye Disease.利福平滴眼剂 5%:用于干燥性眼病的综述。
Drugs. 2017 Feb;77(2):201-208. doi: 10.1007/s40265-016-0681-1.
8
Evaluation of corneal higher order aberrations in normal topographic patterns.正常地形图模式下角膜高阶像差的评估
J Curr Ophthalmol. 2016 Apr 4;28(2):75-80. doi: 10.1016/j.joco.2016.03.001. eCollection 2016 Jun.
9
Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study.5.0% 立他司特滴眼液在干眼症患者中的安全性:一项为期1年的多中心随机安慰剂对照研究。
Cornea. 2016 Jun;35(6):741-8. doi: 10.1097/ICO.0000000000000803.
10
Effectiveness and Optical Quality of Topical 3.0% Diquafosol versus 0.05% Cyclosporine A in Dry Eye Patients following Cataract Surgery.白内障手术后干眼患者中局部应用3.0%双醋瑞因与0.05%环孢素A的有效性及光学质量比较
J Ophthalmol. 2016;2016:8150757. doi: 10.1155/2016/8150757. Epub 2016 Feb 16.